Analysis of mutations at the fragile X locus using the DNA probe Ox1.9

K. Snow, L. Doud, R. Hagerman, C. Hull, M. C. Hirst, K. E. Davies, Stephen N Thibodeau

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

In this study, 40 families segregating for fragile X [fra(X)] syndrome were examined for the presence of a mutation within the FMR-1 gene. Using the DNA probe Ox1.9, both carriers and affected individuals were found to contain an insertion/amplification-type of mutation with somatic instability. Variability in the size of the mutation, which ranged from less than 0.2 kb to approximately 13 kb, was observed both between individuals (even from the same family) and within individuals, who showed a smear rather than a discrete band(s) on Southern blot analysis. Transmission of the mutation by males resulted in little change of its size, while transmission by females usually resulted in an increase in size. Correlations were observed between the size of inserted/amplified DNA and the level of chromosome fragility and the presence or absence of mental impairment. Overall, a mutation was detected in 66 of 67 (99%) clinically affected males, in 12 of 13 (92%) transmitting males and in 95 of 112 (85%) carrier females. Equivocal results were obtained in 12 (11%) of the carrier females. No mutation was detected in 58 females and 33 males predicted to be normal by linkage, or in one female and 36 normal control males. These results strongly suggest that the mutation detected by Ox1.9 is closely associated with the cytogenetic and clinical expression of fra(X) syndrome. Additionally, the use of this probe along with other probe/enzyme combinations should provide a sensitive clinical assay for the detection of carriers of fra(X) syndrome.

Original languageEnglish (US)
Pages (from-to)244-254
Number of pages11
JournalAmerican Journal of Medical Genetics
Volume43
Issue number1-2
DOIs
StatePublished - 1992

Fingerprint

DNA Probes
Fragile X Syndrome
Mutation
Chromosome Fragility
Insertional Mutagenesis
Southern Blotting
Cytogenetics
DNA
Enzymes
Genes

Keywords

  • DNA insertion/amplification
  • FMR-1
  • Fragile X syndrome
  • somatic instability
  • X-linked mental retardation

ASJC Scopus subject areas

  • Genetics(clinical)

Cite this

Analysis of mutations at the fragile X locus using the DNA probe Ox1.9. / Snow, K.; Doud, L.; Hagerman, R.; Hull, C.; Hirst, M. C.; Davies, K. E.; Thibodeau, Stephen N.

In: American Journal of Medical Genetics, Vol. 43, No. 1-2, 1992, p. 244-254.

Research output: Contribution to journalArticle

Snow, K. ; Doud, L. ; Hagerman, R. ; Hull, C. ; Hirst, M. C. ; Davies, K. E. ; Thibodeau, Stephen N. / Analysis of mutations at the fragile X locus using the DNA probe Ox1.9. In: American Journal of Medical Genetics. 1992 ; Vol. 43, No. 1-2. pp. 244-254.
@article{bf0aff3745674b7cb4c667cabfff41a8,
title = "Analysis of mutations at the fragile X locus using the DNA probe Ox1.9",
abstract = "In this study, 40 families segregating for fragile X [fra(X)] syndrome were examined for the presence of a mutation within the FMR-1 gene. Using the DNA probe Ox1.9, both carriers and affected individuals were found to contain an insertion/amplification-type of mutation with somatic instability. Variability in the size of the mutation, which ranged from less than 0.2 kb to approximately 13 kb, was observed both between individuals (even from the same family) and within individuals, who showed a smear rather than a discrete band(s) on Southern blot analysis. Transmission of the mutation by males resulted in little change of its size, while transmission by females usually resulted in an increase in size. Correlations were observed between the size of inserted/amplified DNA and the level of chromosome fragility and the presence or absence of mental impairment. Overall, a mutation was detected in 66 of 67 (99{\%}) clinically affected males, in 12 of 13 (92{\%}) transmitting males and in 95 of 112 (85{\%}) carrier females. Equivocal results were obtained in 12 (11{\%}) of the carrier females. No mutation was detected in 58 females and 33 males predicted to be normal by linkage, or in one female and 36 normal control males. These results strongly suggest that the mutation detected by Ox1.9 is closely associated with the cytogenetic and clinical expression of fra(X) syndrome. Additionally, the use of this probe along with other probe/enzyme combinations should provide a sensitive clinical assay for the detection of carriers of fra(X) syndrome.",
keywords = "DNA insertion/amplification, FMR-1, Fragile X syndrome, somatic instability, X-linked mental retardation",
author = "K. Snow and L. Doud and R. Hagerman and C. Hull and Hirst, {M. C.} and Davies, {K. E.} and Thibodeau, {Stephen N}",
year = "1992",
doi = "10.1002/ajmg.1320430139",
language = "English (US)",
volume = "43",
pages = "244--254",
journal = "American Journal of Medical Genetics, Part A",
issn = "0148-7299",
publisher = "Wiley-Liss Inc.",
number = "1-2",

}

TY - JOUR

T1 - Analysis of mutations at the fragile X locus using the DNA probe Ox1.9

AU - Snow, K.

AU - Doud, L.

AU - Hagerman, R.

AU - Hull, C.

AU - Hirst, M. C.

AU - Davies, K. E.

AU - Thibodeau, Stephen N

PY - 1992

Y1 - 1992

N2 - In this study, 40 families segregating for fragile X [fra(X)] syndrome were examined for the presence of a mutation within the FMR-1 gene. Using the DNA probe Ox1.9, both carriers and affected individuals were found to contain an insertion/amplification-type of mutation with somatic instability. Variability in the size of the mutation, which ranged from less than 0.2 kb to approximately 13 kb, was observed both between individuals (even from the same family) and within individuals, who showed a smear rather than a discrete band(s) on Southern blot analysis. Transmission of the mutation by males resulted in little change of its size, while transmission by females usually resulted in an increase in size. Correlations were observed between the size of inserted/amplified DNA and the level of chromosome fragility and the presence or absence of mental impairment. Overall, a mutation was detected in 66 of 67 (99%) clinically affected males, in 12 of 13 (92%) transmitting males and in 95 of 112 (85%) carrier females. Equivocal results were obtained in 12 (11%) of the carrier females. No mutation was detected in 58 females and 33 males predicted to be normal by linkage, or in one female and 36 normal control males. These results strongly suggest that the mutation detected by Ox1.9 is closely associated with the cytogenetic and clinical expression of fra(X) syndrome. Additionally, the use of this probe along with other probe/enzyme combinations should provide a sensitive clinical assay for the detection of carriers of fra(X) syndrome.

AB - In this study, 40 families segregating for fragile X [fra(X)] syndrome were examined for the presence of a mutation within the FMR-1 gene. Using the DNA probe Ox1.9, both carriers and affected individuals were found to contain an insertion/amplification-type of mutation with somatic instability. Variability in the size of the mutation, which ranged from less than 0.2 kb to approximately 13 kb, was observed both between individuals (even from the same family) and within individuals, who showed a smear rather than a discrete band(s) on Southern blot analysis. Transmission of the mutation by males resulted in little change of its size, while transmission by females usually resulted in an increase in size. Correlations were observed between the size of inserted/amplified DNA and the level of chromosome fragility and the presence or absence of mental impairment. Overall, a mutation was detected in 66 of 67 (99%) clinically affected males, in 12 of 13 (92%) transmitting males and in 95 of 112 (85%) carrier females. Equivocal results were obtained in 12 (11%) of the carrier females. No mutation was detected in 58 females and 33 males predicted to be normal by linkage, or in one female and 36 normal control males. These results strongly suggest that the mutation detected by Ox1.9 is closely associated with the cytogenetic and clinical expression of fra(X) syndrome. Additionally, the use of this probe along with other probe/enzyme combinations should provide a sensitive clinical assay for the detection of carriers of fra(X) syndrome.

KW - DNA insertion/amplification

KW - FMR-1

KW - Fragile X syndrome

KW - somatic instability

KW - X-linked mental retardation

UR - http://www.scopus.com/inward/record.url?scp=0026750370&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026750370&partnerID=8YFLogxK

U2 - 10.1002/ajmg.1320430139

DO - 10.1002/ajmg.1320430139

M3 - Article

C2 - 1605198

AN - SCOPUS:0026750370

VL - 43

SP - 244

EP - 254

JO - American Journal of Medical Genetics, Part A

JF - American Journal of Medical Genetics, Part A

SN - 0148-7299

IS - 1-2

ER -